𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P525 Efficacy infliximab with immunomodulator and infliximab alone of maintenance therapy in children with Crohn's disease – multicenter randomized study

✍ Scribed by Kierkus, J.; Iwanczyk, B.; Wegner, A.; Dadalski, M.; Grzybowska-Chlebowczyk, U.; Lazowska, I.; Maslana, J.; Toporowska-Kowalska, E.; Czaja-Bulsa, G.; Mierzwa, G.; Korczowski, B.; Czkwianianc, E.; Zabka, A.; Szymanska, E.; Krzesiek, E.; Wiecek, S.; Sladek, M.

Book ID
121955879
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
71 KB
Volume
7
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of maintenance inflixi
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease
✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i